Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Rubin

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancer Investigation|January 1, 1993
Interleukin-2: its biology and clinical application in patients with cancerJ T Rubin
Cancer Treatment and Research|January 1, 1995
Interleukin-2: its rationale and role in the treatment of patients with cancerJ T Rubin
Optics Express|November 24, 2011
On optical forces in spherical whispering gallery mode resonatorsJ T Rubin, L Deych
Surgery|March 1, 1992
Acute gastric mucosal injury associated with the systemic administration of interleukin-4J T Rubin, M T Lotze
Radiologic Clinics of North America|May 1, 1992
Immune function and dysfunction. A primer for the radiologistJ T Rubin, M T Lotze
Urology|February 13, 2001
Recurrent metastatic renal cell carcinoma presenting as a bleeding gastric ulcer after a complete response to high-dose interleukin-2 treatmentB Mascarenhas, B Konety, J T Rubin
Cancer Gene Therapy|June 1, 1995
Genetically marking human cells--results of the first clinical gene transfer studiesQ Cai, J T Rubin, M T Lotze
Annals of Surgical Oncology|June 1, 1997
A comparison of locoregional depot and systemic preparations of 9-aminocamptothecin for treatment of liver metastases in a rat tumor model: superior antitumor activity of sustained-release preparationK A Dookeran, A Brumfield, J T Rubin
Current Opinion in Oncology|December 1, 1992
New biologic agents come to bat for cancer therapyM T Lotze, J T Rubin, H J Zeh
Cancer Research|December 15, 1989
Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humansJ T Rubin, L J Elwood, S A Rosenberg, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancer Investigation|January 1, 1993
Interleukin-2: its biology and clinical application in patients with cancerJ T Rubin
Cancer Treatment and Research|January 1, 1995
Interleukin-2: its rationale and role in the treatment of patients with cancerJ T Rubin
Optics Express|November 24, 2011
On optical forces in spherical whispering gallery mode resonatorsJ T Rubin, L Deych
Surgery|March 1, 1992
Acute gastric mucosal injury associated with the systemic administration of interleukin-4J T Rubin, M T Lotze
Radiologic Clinics of North America|May 1, 1992
Immune function and dysfunction. A primer for the radiologistJ T Rubin, M T Lotze
Urology|February 13, 2001
Recurrent metastatic renal cell carcinoma presenting as a bleeding gastric ulcer after a complete response to high-dose interleukin-2 treatmentB Mascarenhas, B Konety, J T Rubin
Cancer Gene Therapy|June 1, 1995
Genetically marking human cells--results of the first clinical gene transfer studiesQ Cai, J T Rubin, M T Lotze
Annals of Surgical Oncology|June 1, 1997
A comparison of locoregional depot and systemic preparations of 9-aminocamptothecin for treatment of liver metastases in a rat tumor model: superior antitumor activity of sustained-release preparationK A Dookeran, A Brumfield, J T Rubin
Current Opinion in Oncology|December 1, 1992
New biologic agents come to bat for cancer therapyM T Lotze, J T Rubin, H J Zeh
Cancer Research|December 15, 1989
Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humansJ T Rubin, L J Elwood, S A Rosenberg, et al.
Pageof 3